RETRACTED: Correlation of ESR, C3, C4, anti-DNA and lupus activity based on British Isles Lupus Assessment Group Index in patients of rheumatology clinic (Retracted article. See vol. 36, pg. 749, 2016)

被引:21
作者
Nasiri, Siavash [1 ]
Karimifar, Mansoor [1 ]
Bonakdar, Zahra Sayed [1 ]
Salesi, Mansour [1 ]
机构
[1] Isfahan Univ Med Sci, Dept Rheumatol, Alzahra Hosp, Esfahan, Iran
关键词
Systemic lupus erythematosus; ESR; C3; C4; Anti-dsDNA; BILAG index; SLEDAI-2K; DISEASE-ACTIVITY INDEXES; ERYTHEMATOSUS ACTIVITY; REVISED CRITERIA; GENETIC-BASIS; VALIDATION; CLASSIFICATION; DR3;
D O I
10.1007/s00296-009-1201-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study aimed to determine the correlation between of ESR, C3, C4, anti-DNA, and lupus activity and also the construct and criterion validity of the British Isles Lupus Assessment Group (BILAG) index for assessing disease activity in systemic lupus erythematosus (SLE). Patients with SLE were recruited into a cross-sectional study. Data were analyzed for estimating of SLE disease activity [scores on the BILAG index and Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K)]. Overall BILAG scores were determined by the highest score achieved in any of the individual systems in the respective index. Erythrocyte sedimentation rates (ESRs), C3 levels, C4 levels, anti-double-stranded DNA (anti-dsDNA) levels, and SLEDAI-2K scores were used in the analysis of construct validity. Statistical analyses were performed using ordinal logistic regression for construct validity. Of the 100 patients with SLE, 90% were women. Their mean +/- A SD age was 31.1 +/- A 9.8 years. Increasing overall scores on the BILAG index were associated with increasing ESRs, decreasing C3 levels, decreasing C4 levels, elevated anti-dsDNA levels, and increasing SLEDAI-2K scores (all P < 0.01). These findings show that the ESR, C3, C4, and anti-DNA should be used in the evaluation and management of patients with SLE. Also the results show that the BILAG index has construct validity.
引用
收藏
页码:1605 / 1609
页数:5
相关论文
共 20 条
[1]  
BATCHELOR JR, 1987, CLIN EXP IMMUNOL, V70, P364
[2]   Serum IL-6, TNFα, p55 srTNFα, p75 srTNFα, srIL-2α levels and disease acitivity in systemic lupus erythematosus [J].
Davas, EM ;
Tsirogianni, A ;
Kappou, I ;
Karamitsos, D ;
Economidou, I ;
Dantis, PC .
CLINICAL RHEUMATOLOGY, 1999, 18 (01) :17-22
[3]  
DAVIES EJ, 1993, BRIT J RHEUMATOL, V32, P870
[4]  
Gladman DD, 2002, J RHEUMATOL, V29, P288
[5]  
GLADMAN DD, 1992, J RHEUMATOL, V19, P608
[6]  
GLADMAN DD, 1994, J RHEUMATOL, V21, P1468
[7]  
GUZMAN J, 1992, J RHEUMATOL, V19, P1551
[8]   THE GENETIC-BASIS OF RO AND LA ANTIBODY-FORMATION IN SYSTEMIC LUPUS-ERYTHEMATOSUS - RESULTS OF A MULTICENTER STUDY [J].
HARTUNG, K ;
EHRFELD, H ;
LAKOMEK, HJ ;
COLDEWEY, R ;
LANG, B ;
KRAPF, F ;
MULLER, R ;
SCHENDEL, D ;
DEICHER, H ;
SEELIG, HP ;
ALBERT, E ;
BAUR, M ;
CORVETTA, A ;
FREY, J ;
KALDEN, JR ;
DELANGE, GG ;
PETER, HH ;
PIRNER, K ;
ROTHER, R ;
SCHNEIDER, P ;
SEUCHTER, S ;
SPATH, P ;
SPECKER, C ;
STANGEL, W ;
STANNATKIESSLING, S .
RHEUMATOLOGY INTERNATIONAL, 1992, 11 (06) :243-249
[9]  
HAY EM, 1993, Q J MED, V86, P447
[10]   Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [J].
Hochberg, MC .
ARTHRITIS AND RHEUMATISM, 1997, 40 (09) :1725-1725